Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A. Anderson, Punit P. Seth, Michael T. Migawa et al.|Nucleic Acids Research|2021Cited by 129
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotidesMichael E. Østergaard, Punit P. Seth, Cheryl Li De Hoyos et al.|Nucleic Acids Research|2020Cited by 98
Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOsGuillermo Vasquez, Punit P. Seth, Michael T. Migawa et al.|Nucleic Acids Research|2021Cited by 47